215 related articles for article (PubMed ID: 22869259)
1. Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter survey.
Son CH; Daniels TL; Eagan JA; Edmond MB; Fishman NO; Fraser TG; Kamboj M; Maragakis LL; Mehta SA; Perl TM; Phillips MS; Price CS; Talbot TR; Wilson SJ; Sepkowitz KA
Infect Control Hosp Epidemiol; 2012 Sep; 33(9):869-74. PubMed ID: 22869259
[TBL] [Abstract][Full Text] [Related]
2. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals.
Worth LJ; Brett J; Bull AL; McBryde ES; Russo PL; Richards MJ
Am J Infect Control; 2009 Oct; 37(8):643-8. PubMed ID: 19589619
[TBL] [Abstract][Full Text] [Related]
3. Central-Line-Associated Bloodstream Infections in Québec Intensive Care Units: Results from the Provincial Healthcare-Associated Infections Surveillance Program (SPIN).
Li L; Fortin E; Tremblay C; Ngenda-Muadi M; Quach C;
Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1186-94. PubMed ID: 27430754
[TBL] [Abstract][Full Text] [Related]
4. Beyond the intensive care unit bundle: Implementation of a successful hospital-wide initiative to reduce central line-associated bloodstream infections.
Klintworth G; Stafford J; O'Connor M; Leong T; Hamley L; Watson K; Kennon J; Bass P; Cheng AC; Worth LJ
Am J Infect Control; 2014 Jun; 42(6):685-7. PubMed ID: 24837122
[TBL] [Abstract][Full Text] [Related]
5. Implementation of a national bundle care program to reduce central line-associated bloodstream infections in intensive care units in Taiwan.
Lai CC; Cia CT; Chiang HT; Kung YC; Shi ZY; Chuang YC; Lee CM; Ko WC; Hsueh PR;
J Microbiol Immunol Infect; 2018 Oct; 51(5):666-671. PubMed ID: 29108783
[TBL] [Abstract][Full Text] [Related]
6. Compliance with prevention practices and their association with central line-associated bloodstream infections in neonatal intensive care units.
Zachariah P; Furuya EY; Edwards J; Dick A; Liu H; Herzig CT; Pogorzelska-Maziarz M; Stone PW; Saiman L
Am J Infect Control; 2014 Aug; 42(8):847-51. PubMed ID: 25087136
[TBL] [Abstract][Full Text] [Related]
7. The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings.
Tedja R; Gordon SM; Fatica C; Fraser TG
Infect Control Hosp Epidemiol; 2014 Feb; 35(2):164-8. PubMed ID: 24442079
[TBL] [Abstract][Full Text] [Related]
8. Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line-associated bloodstream infection rates.
Álvarez-Moreno CA; Valderrama-Beltrán SL; Rosenthal VD; Mojica-Carreño BE; Valderrama-Márquez IA; Matta-Cortés L; Gualtero-Trujillo SM; Rodríguez-Peña J; Linares-Miranda CJ; Gonzalez-Rubio ÁP; Vega-Galvis MC; Riaño-Forero I; Ariza-Ayala BE; García-Laverde G; Susmann O; Mancera-Páez O; Olarte N; Rendón-Campo LF; Astudillo Y; Trullo-Escobar MD; Orellano PW
Am J Infect Control; 2016 Nov; 44(11):e235-e241. PubMed ID: 27317408
[TBL] [Abstract][Full Text] [Related]
9. Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.
Theodoro D; Olsen MA; Warren DK; McMullen KM; Asaro P; Henderson A; Tozier M; Fraser V
Acad Emerg Med; 2015 Sep; 22(9):1048-55. PubMed ID: 26336036
[TBL] [Abstract][Full Text] [Related]
10. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(8):243-8. PubMed ID: 21368740
[TBL] [Abstract][Full Text] [Related]
11. Ten-year surveillance of central line-associated bloodstream infections in South Korea: Surveillance not enough, action needed.
Kim EJ; Kang SY; Kwak YG; Kim SR; Shin MJ; Yoo HM; Han SH; Kim DW; Choi YH;
Am J Infect Control; 2020 Mar; 48(3):285-289. PubMed ID: 31493935
[TBL] [Abstract][Full Text] [Related]
12. Multicenter prospective study on device-associated infection rates and bacterial resistance in intensive care units of Venezuela: International Nosocomial Infection Control Consortium (INICC) findings.
Empaire GD; Guzman Siritt ME; Rosenthal VD; Pérez F; Ruiz Y; Díaz C; Di Silvestre G; Salinas E; Orozco N
Int Health; 2017 Jan; 9(1):44-49. PubMed ID: 28096455
[TBL] [Abstract][Full Text] [Related]
13. Impact of intensified prevention measures on rates of hospital-acquired bloodstream infection in medical-surgical intensive care units, Israel, 2011 to 2019.
Ben-David D; Vaturi A; Wulffhart L; Temkin E; Solter E; Carmeli Y; Schwaber MJ; ;
Euro Surveill; 2023 Jun; 28(25):. PubMed ID: 37347415
[TBL] [Abstract][Full Text] [Related]
14. Prospective surveillance of device-associated health care-associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India.
Kumar S; Sen P; Gaind R; Verma PK; Gupta P; Suri PR; Nagpal S; Rai AK
Am J Infect Control; 2018 Feb; 46(2):202-206. PubMed ID: 29046215
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned from a hospital-wide review of blood stream infections for paediatric central line-associated blood stream infection prevention.
Campbell AJ; Blyth CC; Hewison CJ; Chen YP; Gough L; Goff Z; Bowen AC
J Paediatr Child Health; 2019 Jun; 55(6):690-694. PubMed ID: 30315622
[TBL] [Abstract][Full Text] [Related]
16. Impact of State Reporting Laws on Central Line-Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units.
Liu H; Herzig CTA; Dick AW; Furuya EY; Larson E; Reagan J; Pogorzelska-Maziarz M; Stone PW
Health Serv Res; 2017 Jun; 52(3):1079-1098. PubMed ID: 27451968
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the impact of mandatory public reporting on participation and performance in a program to reduce central line-associated bloodstream infections: evidence from a national patient safety collaborative.
Marsteller JA; Hsu YJ; Weeks K
Am J Infect Control; 2014 Oct; 42(10 Suppl):S209-15. PubMed ID: 25239712
[TBL] [Abstract][Full Text] [Related]
18. Central line-associated bloodstream infections in non-ICU inpatient wards: a 2-year analysis.
Rhee Y; Heung M; Chen B; Chenoweth CE
Infect Control Hosp Epidemiol; 2015 Apr; 36(4):424-30. PubMed ID: 25782897
[TBL] [Abstract][Full Text] [Related]
19. The incidence, aetiology and antimicrobial susceptibility of central line-associated bloodstream infections in intensive care unit patients at a private tertiary care hospital in Mumbai, India.
Singhal T; Shah S; Thakkar P; Naik R
Indian J Med Microbiol; 2019; 37(4):521-526. PubMed ID: 32436874
[TBL] [Abstract][Full Text] [Related]
20. The association between implementation of second-tier prevention practices and CLABSI incidence: A national survey.
Ben-David D; Vaturi A; Solter E; Temkin E; Carmeli Y; Schwaber MJ;
Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1094-1099. PubMed ID: 31339089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
